A carregar...

Aromatase inhibitor use is a risk factor of carotid plaque presence in endocrine-responsive breast cancer patients

BACKGROUND/AIMS: The aromatase inhibitors (AIs) are well known anti-hormonal therapy in endocrine-responsive breast cancer patients. It can lead to dyslipidemia and be the risk factor of cardiovascular disease due to low estrogen level. However, some recent studies comparing AIs with placebo have sh...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Korean J Intern Med
Main Authors: Seo, Da Hea, Cho, Yongin, Lee, Sujin, Park, Seho, Kim, Seung-Il, Park, Byeong Woo, Rhee, Yumie
Formato: Artigo
Idioma:Inglês
Publicado em: The Korean Association of Internal Medicine 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6506747/
https://ncbi.nlm.nih.gov/pubmed/28838227
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2016.205
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!